Lifecare ASA — Earnings Release 2024

Nov 5, 2024

Lifecare ASA Q3 2024 presentation

Lifecare ASA Q3 2024 presentation

Lifecare ASA will release its third quarter 2024 results on Wednesday 13

November 2024 at 07:00 a.m. CET.

The same day at 11:00 CET, the CEO Joacim Holter will present the results live

at Carnegie AS, Fjordalleen 16, Aker Brygge in Oslo.

After the presentation, Lifecare invites to 1:1 session with the CEO and the

CFO.

To register for physical attendance and 1:1 meeting, please send an email to

ca@carnegie.no (mailto:ca@cartnegie.no). To access the live webcast Join the

Teams-meeting here

(https://teams.microsoft.com/l/meetup-join/19%3ameeting_ZmFmNTAzNTQtM2M2YS00Mjg1LWJlNjEtMGM0YzcxY2U5MWE1%40thread.v2/0?context={"Tid"%3a"904e2f8f-5832-43bf-aea8-7cbfde1c5d4c"%2c"Oid"%3a"382475a7-cf90-4587-b322-8c2dfa57332e"})

About us

Lifecare ASA is a clinical stage medical sensor company developing technology

for sensing and monitoring of various body analytes. Lifecare's main focus is

to bring the next generation of Continuous Glucose Monitoring ("CGM") systems

to market. Lifecare enables osmotic pressure as sensing principle, combined

with the ability to manipulate Nano-granular Tunnelling Resistive sensors

("NTR") on the sensor body for read-out of pressure variations. Lifecare's

sensor technology is referred to as "Sencell" and is suitable for identifying

and monitoring the occurrence of a wide range of analytes and molecules in the

human body and in pets.

Contacts

For further information, please contact:

Joacim Holter, CEO, joacim.holter@lifecare.no, +47 40 05 90 40

Renete Kaarvik, CFO, renete.kaarvik@lifecare.no, +47 94 83 82 42